Pasar al contenido principal

PAPEL DE LA VIA AKT-YAP/TAZ EN PATOLOGIAS DEL SISTEMA NERVIOSO CENTRAL

RTI2018-096303-B-C31

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

WIP modulates oxidative stress through NRF2/KEAP1 in glioblastoma cells

  • Escoll, Maribel
  • Lastra, Diego
  • Robledinos-Antón, Natalia
  • Wandosell, Francisco
  • Antón, Inés María
  • Cuadrado, Antonio
Due to their high metabolic rate, tumor cells produce exacerbated levels of reactive oxygen species that need to be under control. Wiskott–Aldrich syndrome protein (WASP)-interacting protein (WIP) is a scaffold protein with multiple yet poorly understood functions that participates in tumor progression and promotes cancer cell survival. However, its participation in the control of oxidative stress has not been addressed yet. We show that WIP depletion increases the levels of reactive oxygen species and reduces the levels of transcription factor NRF2, the master regulator of redox homeostasis. We found that WIP stabilizes NRF2 by restraining the activity of its main NRF2 repressor, the E3 ligase adapter KEAP1, because the overexpression of a NRF2ΔETGE mutant that is resistant to targeted proteasome degradation by KEAP1 or the knock-down of KEAP1 maintains NRF2 levels in the absence of WIP. Mechanistically, we show that the increased KEAP1 activity in WIP-depleted cells is not due to the protection of KEAP1 from autophagic degradation, but is dependent on the organization of the Actin cytoskeleton, probably through binding between KEAP1 and F-Actin. Our study provides a new role of WIP in maintaining the oxidant tolerance of cancer cells that may have therapeutic implications., This work was supported by PID2019-110061RB-I00, RTI2018-096303-B-C31 and SAF2017-82436R of the Spanish Ministry of Economy and Competiveness; and by the P_37_732/2016 grant (REDBRAIN) financed by the European Regional Development Fund, Competitiveness Operational Program 2014–2020, and Comunidad Autónoma de Madrid (grant B2017/BMD-3827). M.E. was recipient of a postdoctoral contract Juan de la Cierva; D.L. and N.R.-A. enjoied a FPU contract of MINECO., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Chapter 15 - Cancer cell development, migratory response, and the role of the tumor microenvironment in invasion and metastasis

  • Antón, Inés María
  • Wandosell, Francisco
  • Vicente-Manzanares, Miguel
Acquisition of motile capability is one of the most tantalizing features of the oncogenic cell transformation program. Cancer cell migration borrows heavily from normal morphogenetic processes that are activated during embryonic differentiation and tissue growth. Tumor cell migration is triggered by genetic modifications that activate transcriptional programs, e.g., the epithelial–mesenchymal transition, which lie dormant in healthy tissues. These programs allow cells to generate structures that enable them to move and manipulate the extracellular matrix to favor their dissemination, e.g., invadopodia. Collectively, these processes not only affect the cancer cells themselves, but also trigger modifications of the tumor microenvironment, aggressively promoting tumor growth and dissemination. As such, cancer cell migration not only depends on the genetic changes that are the most important element of oncogenic transformation; but it is also influenced by the mechanochemical makeup of the tumor microenvironment. In this chapter, we describe the changes that enable tumor cells to become migratory. We also address the cellular and acellular composition of the tumor microenvironment as it controls cancer growth and migration, from small tumors made of a few cells to large, invasive masses that have the ability to form distal metastasis., IMA and FW acknowledge funding from the Fundación Ramón Areces (CIVP18A3861) and Spanish Ministry of Science and Innovation (RTI2018-096303-B-C31), which was in part granted with FEDER funding (EC), corresponding to the Programa Estatal de Investigación, Desarrollo e Innovación Orientada a los Retos de la Sociedad. M-VM acknowledges funding from the Spanish Ministry of Science and Innovation (SAF2017-87408, PID2020-116232-PB-I00), AECC Seed award (2018–IDEAS18018VICE), and ECRIN-M3 from AECC/AIRC/CRUK. IBMCC is supported by the Programa de Apoyo a Planes Estratégicos de Investigación de Estructuras de Investigación de Excelencia of the Ministry of Education of the Castilla–León Government (CLC–2017–01).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Clearance of ß-amyloid mediated by autophagy is enhanced by MTORC1 inhibition but not AMPK activation in APP/PSEN1 astrocytes

  • García-Juan, Marta
  • Ordóñez-Gutiérrez, Lara
  • Wandosell, Francisco
Proteostasis mechanisms mediated by macroautophagy/autophagy are altered in neurodegenerative diseases such as Alzheimer disease (AD) and their recovery/enhancement has been proposed as a therapeutic approach. From the two central nodes in the anabolism-catabolism balance, it is generally accepted that mechanistic target of rapamycin kinase complex 1 (MTORC1)_ activation leads to the inhibition of autophagy, whereas adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK) has the opposite role. In AD, amyloid beta (Aß) production disturbs the optimal neuronal/glial proteostasis. As astrocytes are essential for brain homeostasis, the purpose of this work was to analyze if the upregulation of autophagy in this cell type, either by MTORC1 inhibition or AMPK activation, could modulate the generation/degradation of ß-amyloid. By using primary astrocytes from amyloid beta precursor protein (APP)/Presenilin 1 (PSEN1) mouse model of AD, we confirmed that MTORC1 inhibition reduced Aß secretion through moderate autophagy induction. Surprisingly, pharmacologically increased activity of AMPK did not enhance autophagy but had different effects on Aß secretion. Conversely, AMPK inhibition did not affect autophagy but reduced Aß secretion. These puzzling data were confirmed through the overexpression of different mutant AMPK isoforms: while only the constitutively active AMPK increased autophagy, all versions augmented Aß secretion. We conclude that AMPK has a significantly different role in primary astrocytes than in other reported cells, similar to our previous findings in neurons. Our data support that perhaps only a basal AMPK activity is needed to maintain autophagy whereas the increased activity, either physiologically or pharmacologically, has no direct effect on autophagy-dependent amyloidosis. These results shed light on the controversy about the therapeutic effect of AMPK activation on autophagy induction., PI2016/01/Spanish FEDER/Science and Innovation Ministry PID2021-124801NB-I00/Spanish FEDER/Science and Innovation Ministry Proyectos I+D+i-RETOS-PID2021-124801NB-I00/Spanish FEDER/Science and Innovation Ministry I+D+i-RETOS-RTI2018-096303-B-C1/Spanish FEDER/Science and Innovation Ministry FPU18/05727/Spanish FEDER/Science and Innovation Ministry Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) Fundación Ramón Areces and Banco Santander
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Pathways Involved in Remyelination after Cerebral Ischemia

  • Garcia-Martin, Gonzalo
  • Alcover-Sanchez, Berta
  • Wandosell, Francisco
  • Cubelos, Beatriz
Brain ischemia, also known as ischemic stroke, occurs when there is a lack of blood supply into the brain. When an ischemic insult appears, both neurons and glial cells can react in several ways that will determine the severity and prognosis. This high heterogeneity of responses has been a major obstacle in developing effective treatments or preventive methods for stroke. Although white matter pathophysiology has not been deeply assessed in stroke, its remodelling can greatly influence the clinical outcome and the disability degree. Oligodendrocytes, the unique cell type implied in CNS myelination, are sensible to ischemic damage. Loss of myelin sheaths can compromise axon survival, so new Oligodendrocyte Precursor Cells are required to restore brain function. Stroke can, therefore, enhance oligodendrogenesis to regenerate those new oligodendrocytes that will ensheath the damaged axons. Given that myelination is a highly complex process that requires coordination of multiple pathways such as Sonic Hedgehog, RTKs or Wnt/β-catenin, we will analyse new research highlighting their importance after brain ischemia. In addition, oligodendrocytes are not isolated cells inside the brain, but rather form part of a dynamic environment of interactions between neurons and glial cells. For this reason, we will put some context into how microglia and astrocytes react against stroke and influence oligodendrogenesis to highlight the relevance of remyelination in the ischemic brain. This will help to guide future studies to develop treatments focused on potentiating the ability of the brain to repair the damage., RTI2018-096303B-C33, RTI2018-096303-B-C31/Spanish Ministry of Economy and Competitiveness B2017/BMD-3700/Comunidad de Madrid CAM-Biomedicina PI2016/01/Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED)